The Association of British Clinical Diabetologists

Dapagliflozin (Forxiga): no longer authorised for treatment of type 1 diabetes mellitus

As of 25th October 2021, dapagliflozin 5mg is no longer authorised for the treatment of people with type 1 diabetes mellitus (T1DM) and should no longer be used in this population . This is based on AstraZeneca’s decision to remove the Type 1 diabetes indication for dapagliflozin 5mg.

ABCD are disappointed that the use of dapaglifozin has been withdrawn for people with type 1 diabetes.

This is not due to any safety concern for dapagliflozin in any indication, including people with type 1 diabetes.

Read more about Dapagliflozin (Forxiga): no longer authorised for treatment of type 1 diabetes mellitus

Investigating the Impact of a Dedicated Diabetes-Stroke Multi-Disciplinary Team (D/S-MDT) on Patient Outcomes, Referrals and Staff Satisfaction

Read more about Investigating the Impact of a Dedicated Diabetes-Stroke Multi-Disciplinary Team (D/S-MDT) on Patient Outcomes, Referrals and Staff Satisfaction

Raunak Chugani Chandiramani, Laura Storey, Mina Mansor, Neil Hill

Imperial College London

The rare occurrence of Type B insulin resistance syndrome (TBRIS) in a T1DM patient. Could an insulin pump be the solution?

Read more about The rare occurrence of Type B insulin resistance syndrome (TBRIS) in a T1DM patient. Could an insulin pump be the solution?

Melvin Lee Yoong Zher, Andrew Pettit

Department of Diabetes and Endocrinology, Division of Internal Medicine, Airedale General Hospital

Flash blood glucose monitoring (Freestyle Libre) improves glycemic control and reduces hospital admissions for diabetic ketoacidosis and severe hypoglycemia in community dwelling people with type 1 diabetes receiving limited specialist care

Read more about Flash blood glucose monitoring (Freestyle Libre) improves glycemic control and reduces hospital admissions for diabetic ketoacidosis and severe hypoglycemia in community dwelling people with type 1 diabetes receiving limited specialist care

Yin WL; Wong E; Moses J; Minton D; Hussain R; Obuobie K

oyal Gwent Hospital, Newport, Ysbyty Ystrad Fawr, General Practice; Aneurin Bevan University Health Board

Screening for gestational diabetes: Comparing NICE criteria vs. RCOG criteria recommended during the Covid pandemic – role of HbA1c in GDM screening

Read more about Screening for gestational diabetes: Comparing NICE criteria vs. RCOG criteria recommended during the Covid pandemic – role of HbA1c in GDM screening

Varughese MS, Nayak AU

University Hospital of North Midlands NHS Trust, Stoke on Trent

Mental health case-management significantly reduces hospital admissions and bed days in adults with Type 1 Diabetes Mellitus

Read more about Mental health case-management significantly reduces hospital admissions and bed days in adults with Type 1 Diabetes Mellitus

Subramaniam Y¹, Huda M¹, Garrett C^1,2

1 Department of Diabetes and Metabolism, Royal London Hospital, Barts Health NHS Trust
2 Department of Psychological Medicine, Royal London Hospital, East London Foundation Trust

Outcomes in patients with lipodystrophy receiving treatment with metreleptin via the National Severe Insulin Resistance Service at Addenbrookes Hospital, Cambridge

Read more about Outcomes in patients with lipodystrophy receiving treatment with metreleptin via the National Severe Insulin Resistance Service at Addenbrookes Hospital, Cambridge

Stears AJ; Flanagan CL, Gaff L; Gorman S; Jenkins-Liu C: Savage DB; Williams R; Withers E; O’Rahilly S

Wolfson Centre for Diabetes and Endocrinology, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge

Empagliflozin Reduced the Total Burden of Events Leading to or Prolonging Hospitalisation in EMPA-REG OUTCOME

Read more about Empagliflozin Reduced the Total Burden of Events Leading to or Prolonging Hospitalisation in EMPA-REG OUTCOME

Gary Solomons¹, Silvio E. Inzucchi², Christoph Wanner³, David Fitchett⁴, Bernard Zinman⁵, Stefan D. Anker⁶, Michaela Mattheus⁷, Ola Vedin⁸, Stefan Hantel⁹, Søren S. Lund¹⁰

Factors associated with the difference in HbA1c and FreeStyle Libre Glucose management indicator (GMI) in patients with type 1 diabetes

Read more about Factors associated with the difference in HbA1c and FreeStyle Libre Glucose management indicator (GMI) in patients with type 1 diabetes

Priya Sarkar¹, Manushri Jain^1,2, Tejas Kalaria², Brett Healey¹, Rajeev Raghavan¹, Rousseau Gama²

1 Diabetes and Endocrinology, New Cross Hospital, Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP

2 Clinical Biochemistry, New Cross Hospital, Black Country Pathology Services, Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP

Implementation of Joint Society Guidance on Diabetes (COVID:Diabetes): Dexamethasone/Glucocorticosteroid Therapy In Covid-19 Patients during the COVID-19 Pandemic in a District General Hospital

Read more about Implementation of Joint Society Guidance on Diabetes (COVID:Diabetes): Dexamethasone/Glucocorticosteroid Therapy In Covid-19 Patients during the COVID-19 Pandemic in a District General Hospital

G Roulston; J Harding J; R Harper; CM McHenry; E McKeever; P McMullan

Ulster Hospital, South Eastern Health and Social Care Trust, Dundonald, Belfast

Subscribe to The Association of British Clinical Diabetologists